AGXT and asthma: Both allergic status (defined on the basis of SPT positivity or negativity) and age of asthma onset (<40 or ≥40 years) were not shown to be associated with the reported improvements in clinical and functional outcomes, thereby corroborating the results of other real-life studies [21,39].